Home
overview

This year marks SMi’s 8th annual conference on Biobanking which will take place on 13th & 14th June 2018 in London, United Kingdom. The event will bring together internationally recognised biorepositories, scientific pioneers from pharmaceutical companies, and academics to strengthen current knowledge in biosample management and their research applications. Further, the event will dive into application of novel technologies and security software associated to the protection of data.


The conference will aim to broaden the understanding of the ethical and regulatory frameworks, as well as defining the impact that the General Data Protection Regulation (GDPR) will have in 2018. The conference also aims at defining some amongst the most successful applications of biosamples in the market. Speakers are the result of a careful selection of experts in the industry and will include: directors of biorepositories, professionals working in regulatory agencies, drug discovery program directors and legal advisors.

Join us in June to take part in cutting-edge discussions through a series of interactive presentations, panel discussions and case-studies addressing all the critical issues regarding the improvement of Biobanking: a market that is expected to reach USD 2.69 Billion by 2022 from USD 1.85 Billion in 2017, at a CAGR of 7.8%.*


*Research and Markets. “Biobanking Market 2017: Global Forecast to 2022.” PR Newswire: News Distribution, Targeting and Monitoring, PR Newswire, 17 Aug. 2017, www.prnewswire.com/news-releases/biobanking-market-2017---global-forecast-to-2022---advances-in-biobanking-and-growing-trend-of-conserving-cord-blood-stem-cells-of-newborns-300505938.html.
 

The event will bring together internationally recognised biorepositories, scientific pioneers from pharmaceutical companies, and academics to strengthen current knowledge in biosample management and their research applications. Further, the event will dive into application of novel technologies and security software associated to the protection of data.
 

• Discuss the application of novel GPDR regulations with regards to Biomaterials.
• Develop a strong understanding of the uses of Biomaterials in research.
• Evaluate the advantages and disadvantages of constructing shared-data networks such as national databases.
• Explore the importance of characterisation, standardisation and quality control of biomaterials.
• Learn about the different experiences of experts that work with biomaterials in different countries and with different uses.
• Discuss laboratory guidelines aimed at optimising the storage and transport of biomaterials.

Heads of Department, Directors, Managers, Team Leaders of:

Biobanks
Biorepositories
Biological Sample Management Centres
Genomic and Pharmacogenomic Research
Pathology Research Groups
Personalised Medicine and Translational Medicine Centres
Lab Management
Inventory Management
Molecular Technologies
Biologics Research
Data Privacy/Protection/Security Officers
Quality Control and Quality Management
Research and Development
Supply Chain and Cold Chain Distributors
Population-based Biobanks
Disease-based Biobanks
Hospital Trusts
Research Institutes
Technology Transfer Centres
Bio-innovation Centre
 

Ankara Yildirim Beyazit University; Auria Biobank; BioKryo GmbH; Biostor Ireland; Brooks Life Science Systems; BWB; Cambridge Blood and Stem Cell Biobank; European Commission; European Sperm Bank; Human Tissue Authority; Imperial College; Institute Of Child Health; Institute of Child Health University College London; Institute Of Food Research (I F R); Istanbul Medipol University; Karadeniz Technical University; King’s College London; Liconic; Liconic UK; LifelinesNL; London School of Hygiene & Tropical Medicine; Merck Research Laboratories; MRC CTU at UCL; National Institute For Biological Standards & Control; National Institute for Biological Standards and Control; Nottingham University Hospital NHS Trust; Regeneron Pharmaceuticals Inc; Scientist.com; The Faroese Biobank; Thermo Fisher Scientific; UCL; UCL Institute of Neurology; UK Biocentre; UKCRC Tissue Directory and Coordination Centre; University Hospital of South Manchester NHS Foundation Trust; University of Nottingham;

Conference programme

8:30 Registration & Coffee

9:00 Chairman's Opening Remarks

Brian Thomson

Brian Thomson, Director of Research and Development, University of Nottingham
View Bio

9:10 Scaling biobanks with low-pass sequencing and digital phenotyping

Joe Pickrell

Joe Pickrell, CEO, Gencove

• Low-pass sequencing refers to a genome that is sequenced to a depth under 10x. This type of data is useful to call germline single-nucleotide pairs (SNPs), find structural variants and offers a very complete ascertainment of shared variation.
• Digital phenotyping is a multidisciplinary field of science, defined as the “moment-by-moment quantification of the individual-level human phenotype in situ using data from personal digital devices,” with particular focus on smartphones.
• Digital phenotyping offers two types of data: active data and passive data. The former refers to data that requires active input from the users to be generated, whereas passive data, such as sensor data and phone usage patterns, are collected without requiring any active participation from the user.
• Smartphone data can be used to study behavioural patterns, social interactions, physical mobility, gross motor activity, and speech production, among others. Ownership has been in steady rise globally over the past years.
 

9:50 ISO 20387 - A New International Standard for Biobanking

Gareth Bicknell

Gareth Bicknell, Biobank Operations Manager, Human Biomaterials Resource Centre, University of Birmingham
View Bio

• The importance of international minimum standards in enabling resource interoperability and enhanced quality of scientific results
• An introduction to the purpose, content, and limitations of ISO 20387
• What next? Moving forward from the horizontal standard
 

10:30 Morning Coffee

11:00 Design and qualification of a cloud-based biosample information management system

Peadar Mac Gabhann

Peadar Mac Gabhann, Managing Director, Biostor Ireland
View Bio

  • Workflow process mapping and user requirements specification
  • GDPR requirements
  • System qualification and validation
  • Ethics and consent and open science cloud
  • 11:40 Uk Biobank: Ethics and Regulations

    Christopher Perrett

    Christopher Perrett, Regulation Manager, Human Tissue Authority
    View Bio

    • Ethical approval of UK Biobanks: The role of the Health Research Authority (HRA)
    • Regulation of UK Biobanks: The role of the Human Tissue Authority (HTA)
     

    12:20 Networking Lunch

    13:20 Generating High Quality Biological Samples for High Quality Research.

    Kristian Spreckley

    Kristian Spreckley, Business Development Director, UK Biocentre
    View Bio

    • Sample linkage – establishing accurate linkage of patient and sample data.
    • Sample logistics – maintaining sample integrity during transportation.
    • Sample processing – The importance of sample and data tracking during processing tasks.
    • Sample storage – Creating accurate sample traceability during storage and retrieval activities.
    • LIMS – A fundamental prerequisite to successful sample and data traceability.

    14:00 Genome-Wide Association Studies: Generation Scotland and VIKING Cohorts

    Shona Kerr

    Shona Kerr, Project Manager, MRC Human Genetics Unit
    View Bio

    • Genome-Wide Association Studies (GWAS) of health-related measures and markers of genetic risk
    • NHS electronic health record (EHR) and genomics analyses in consented populations
    • Governing biobanks: data and sample sharing and managed access
    • Are smaller biobanks still useful (and sustainable) in the era in the era of 500,000 plus cohorts?
     

    14:40 Adopting a Platform Economy Based Approach to Support Scientific Research by Gathering Biobanks and other Healthcare and Genomic Data Providers in a Worldwide Network

    Heli Salminen-Mankonen

    Heli Salminen-Mankonen, Director, Auria Biobank
    View Bio

    • Digital platforms are the most effective business models for future economies and societies where open data, high value creation with new innovations and the network effects form the basis of the activities.
    • Still, the biggest healthcare challenges today is to manage, analyse, and interpret the growing amount of complex genomic and other omics as well as the other health related data in a systematic and secure manner.
    • Due to this, the digital platform (RQUEST) between the data producers (biobanks, hospitals and national data driven initiatives) and users (pharma industry and academic research groups) to revolutionise research and development by providing a marketplace and network for turning health related real-world data into real-world evidence needs to be adopted.
     

    15:20 Afternoon Tea

    15:50 FinnGen: A Long-Term Disease Association National Project

    Aarno Palotie

    Aarno Palotie, Research Director, Finland Institute for Molecular Medicineá
    View Bio

    • Further development of linkage to health-related datasets (i.e. for primary care as well as for death, cancer and hospitalisation).
    • Further development of outcome adjudication processes (i.e. scalable approaches for large number and range of outcomes).
    • Further development of data storage and access systems, and maintenance/development of the sample archives.
    • Complete ongoing funded enhancements: genotyping (and telomere assays), biochemical assays and imaging assessments.
     

    16:30 Dublin Brain Bank: A resource for the study of neurological disorders

    Jennifer Lorigan

    Jennifer Lorigan, Lead Mediator, Dublin Brain Bank
    View Bio

    • The need for a designated brain biobank
    • The process of donation and tissue use
    • Demographics and neurodegenerative disorders represented in the brain bank
    • A retrospective study of neuropathologic sign specificity
     

    8:30 Registration & Coffee

    9:00 Chairman's Opening Remarks

    Brian Thomson

    Brian Thomson, Director of Research and Development, University of Nottingham
    View Bio

    9:10 INFANT – Translational research, Stem Cell-based products and customised workflows for Biobanks

    Emma Snapes

    Emma Snapes, Biobank Manager, INFANT, University College Cork
    View Bio

    • Managing the lifecycle of clinical assets to better enable advancements in translational research - working to currently accepted best practices: ISBER, OECD and MMI guidelines..
    • Why is it crucial to the efficiency of manufacture and the efficacy of cell therapies?
    • How: Careful monitoring, procedural controls and novel technologies.
    • Creating customised workflows for biobanks which are split across continents in multi-centred studies.
    • New cell and tissue types are required for therapy, and will need new technological and scientific developments
     

    9:50 Advances in the field of biobanking and relevant case studies

    10:30 Morning Coffee

    11:00 Data Protection in a Digitalised World

    11:40 Bayer’s concept of two biobanks in Research & Development

    Johanna Beekman

    Johanna Beekman, Head Biosample Management, Bayer
    View Bio

    • Providing our research departments with high quality biological specimens for the purpose of target identification and validation, biomarker assay development and validation and develop of companion diagnostics (Bayer's Research Biobank)
    • Enabling the optimal use of biological specimens collected in Bayer's global clinical trials for the thorough investigation of the investigational product and the treated disease (Bayer's Clinical Sample Repository)
    • Ensuring that these biological specimens are collected according to the appropriate guidelines, ethical standards and ensuring high standards of data privacy.
    • Linking the biological specimens and generated biomarker data with the corresponding clinical data through an innovative platform
     

    12:20 Networking Lunch

    13:20 Biobanking in the future: Challenges and Opportunities

    Karine Sargsyan

    Karine Sargsyan, Leader of Biobank Graz, Medical University of Graz
    View Bio

  • Biobanking at Medical University of Graz
  • Developments in Biobanking - The last ten years
  • Automation
  • Challenges and opportunities
  • 14:00 Banking of clinical grade human Pluripotent Stem Cells

    Sofia Spyrou

    Sofia Spyrou, Project Manager, UK Stem Cell Bank
    View Bio

    • The UK Stem Cell Bank is a key partner of the UK regenerative medicine infrastructure, charged with procuring, processing and distributing seed stocks of human embryonic stem cell lines for research and clinical application.
    • One of the key objectives of the UKSCB is to bank and release stem cell lines that meet the EU Tissue and Cell Directives (EUTCD) criteria as set out in Human Tissue Authority regulations.
    • 38 ethically sourced human embryonic stem cell lines have been approved for deposit as EUTCD-Grade by the UK Steering Committee, and over 10 lines have been banked on feeders are already available from the UK Stem Cell Bank.
    • The UK Stem Cell Bank is currently focusing its activities on supplying feeder-free deeply characterised EUTCD-grade human embryonic stem cell lines, to support the regenerative medicine community in the development of quality and safety-assured cell therapies.
     

    14:40 Afternoon Tea

    15:10 Long-term biobanking: How long can you hold samples?

    Marybeth Joshi

    Marybeth Joshi, Assistant Director, Duke University School of Medicine
    View Bio

    • The amount of biological material requiring storage increases, it is therefore vital to be able to accurately log and store samples in a robust, inert environment ensuring sample integrity. The ability to select and retrieve only the samples required, limiting any potential freeze-thawing of unselected samples is now a standard requirement in the biomedical research industry today.
    • In order to prevent a loss of integrity among samples experts involved in the collection and storage of biospecimens must follow certain practices. These procedures should be based on up-to-date, relevant research studies that demonstrate the most effective methods for storing specimens, as well as the maximum length of time they can be stored safely.
    • For long-term biobanking, understanding your sample's limitations is essential. Some of the information provided should be used as a guide to determine the best practices for storing your samples so that you can maximize their shelf life and ensure that they are viable when you need them.
     • In maintaining a long-term biobank it is important  to focus on preservation and creating value through the linkage of clinical and/biological data. 
    • For long-term biobanking, understanding your samples  value and limitations are essential. Some of the information provided should be used as a guide for best practices for sample storage and value creation through data linkage so that you can maximize the shelf life and ensure the samples are viable and have relevant value when needed.
     

    15:50 Stratified medicine and biobank integration in hospital routine

    Brian Thomson

    Brian Thomson, Director of Research and Development, University of Nottingham
    View Bio

    • Stratified medicine is based on identifying subgroups of patients with distinct mechanisms of disease, or particular responses to treatments, with the aim of us to identify and develop treatments that are effective for particular groups of patients.
    • A biobank as a repository of biological specimens and linked clinical data has the potential to provide an ideal knowledge and data platform for the delivery of stratified and personalised medicine.
    • In order to do fulfil this key role so biobanks will be required to navigate stringent governance, ethical and logistic barriers to full integration with clinical services
    • A strategy for doing so will be discussed
     

    16:30 Chairman’s Closing Remarks and Close of Day Two

    Brian Thomson

    Brian Thomson, Director of Research and Development, University of Nottingham
    View Bio

    +

    FEATURED SPEAKERS

    Aarno Palotie

    Aarno Palotie

    Research Director, Finland Institute for Molecular Medicineá
    Brian Thomson

    Brian Thomson

    Director of Research and Development, University of Nottingham
    Christopher Perrett

    Christopher Perrett

    Regulation Manager, Human Tissue Authority
    Emma Snapes

    Emma Snapes

    Biobank Manager, INFANT, University College Cork
    Gareth Bicknell

    Gareth Bicknell

    Biobank Operations Manager, Human Biomaterials Resource Centre, University of Birmingham
    Heli Salminen-Mankonen

    Heli Salminen-Mankonen

    Director, Auria Biobank
    Joe Pickrell

    Joe Pickrell

    CEO, Gencove
    Johanna Beekman

    Johanna Beekman

    Head Biosample Management, Bayer
    Kristian Spreckley

    Kristian Spreckley

    Business Development Director, UK Biocentre
    Marybeth Joshi

    Marybeth Joshi

    Assistant Director, Duke University School of Medicine
    Peadar Mac Gabhann

    Peadar Mac Gabhann

    Managing Director, Biostor Ireland
    Shona Kerr

    Shona Kerr

    Project Manager, MRC Human Genetics Unit
    Sofia Spyrou

    Sofia Spyrou

    Project Manager, UK Stem Cell Bank

    Aarno Palotie

    Research Director, Finland Institute for Molecular Medicineá
    Aarno Palotie

    Aarno Palotie, M.D., Ph.D. is the research director of the Human Genomics program at FIMM, a faculty member at the Center for Human Genome Research at the Massachusetts General Hospital in Boston and associate member of the Broad Institute of MIT and Harvard. He has a long track record in human disease genetics. He has previously hold professorships and group leader positions at the University of Helsinki, UCLA, Wellcome Trust Sanger Institute. He is the Chief Scientific Officer of the large FinnGen project that collects the genome and health record data from 500 000 Finnish participants.

    Brian Thomson

    Director of Research and Development, University of Nottingham
    Brian Thomson

    Dr Brian Thomson qualified in medicine from the University of Edinburgh and trained in Edinburgh, London and Cambridge before becoming Associate Professor and Honorary Consultant in Nottingham. He has held MRC Training and Clinician Scientist Fellowships in London and Cambridge and was awarded a PhD in 1992. Dr Thomson is founder and Director of the Nottingham Health Science Biobank (NHSB). The NHSB is the only NHS led Biobank in England and brings together a centralised quality assured tissue resource and an innovative informatics strategy to provide a unique platform for research. Dr Thomson leads the NHSE 100,000 Genome Project in Nottingham and is co-investigator for the UKCRC Tissue Directory and Co-ordination Centre.
     

    Christopher Perrett

    Regulation Manager, Human Tissue Authority
    Christopher Perrett

    Chris is Regulation Manager at the Human Tissue Authority (HTA) and is part of the Regulation Directorate. He leads inspections in all of the HTA’s sectors (especially the research sector), develops policies for the sectors, is involved in training, and is part of the team developing strong links with stakeholders and other organisations. These include the Health Research Authority (HRA), the Medicines and Healthcare products Regulatory Agency (MHRA), the Human Fertilisation and Embryology Authority (HFEA), NHS Blood and Transplant (NHSBT) and the United Kingdom Accreditation Service (UKAS).


    Chris is also Guidance Project Manager at the HRA, where he has worked since February 2016. As a member of the Quality, Standards and Information Directorate, he is involved in reviewing the Integrated Research Application System (IRAS) for Research Tissue Banks (RTBs) and research projects. He has also been involved in developing the HRA E-learning package on research involving human tissue.


    Chris’s previous background was in research. He holds a degree in Natural Sciences and an MSc and PhD in Molecular Oncology. His previous career was in academia. He was a senior lecturer in oncology at University College London (UCL) and led a research team investigating the causes and treatment of breast and ovarian cancer.
     

    Emma Snapes

    Biobank Manager, INFANT, University College Cork
    Emma Snapes

    Emma is INFANT’s Biobank Manager based in University College Cork and Cork University Maternity Hospital (www.infantcentre.ie). She has had responsibility for the biobank repository since the inception of the SCOPE pregnancy study in Cork University Maternity Hospital in 2008. Her expertise lies in managing the lifecycle of precious clinical assets to better enable advancements in translational research, working to currently accepted best practices: ISBER, OECD and MMI guidelines. She specialises in the creation of customised workflows for biobanks split across continents in multi-centred studies.
     

    Emma’s passion for long term cold storage of biological samples has seen her consult with emerging and established biobanks both in Ireland and internationally, particularly in the perinatal area. Her particular areas of interest are the sustainability of biobanks and the creation of global standards in the biobanking field. Emma is the Irish national academic representative for ISO TC 276 for WG2 Biobanking and Bioresources and a member of the Education and Training Committee of ESBB. She is eager to share experiences and values a cohesive grassroots approach to the challenges involved in biobanking.
     

    Gareth Bicknell

    Biobank Operations Manager, Human Biomaterials Resource Centre, University of Birmingham
    Gareth Bicknell

    From 2004 - 2011 Dr Bicknell managed a human tissue-processing facility at the University of Leicester, reconfiguring its voluntary MHRA accreditation into an HTA licence for Human Application. In 2006/2007 he also assisted the HTA perform its first round of inspections. In 2011 he moved into quality/general management at the University of Oxford’s licensed musculoskeletal biobank, and in 2015 he became Operations Manager at the University of Birmingham’s HBRC. Currently he oversees a team ensuring that 4500 samples/month are handled efficiently, securely, confidentially, and with quality assurance. Since 2016, he has actively contributed to the new ISO 20387 standard for biobanking.

    Heli Salminen-Mankonen

    Director, Auria Biobank
    Heli Salminen-Mankonen

    CURRENT POSITION: Research Director, Digital Futures, University of Turku and Scientific Advisor at BC Platforms
    EDUCATION AND TRAINING: University of Turku, Faculty of Medicine, 1998, Ph.D. 2000, Docent, University Of Turku, 2006. Postdoctoral Fellow, Imperial College, London, UK, 2002-2003.
    PERSONAL SKILLS AND COMPETENCES: The founding member and head of the Auria Biobank (currently LOA ), the first hospital biobank in Finland based on the current legislation. During last few years more than 40 invited lectures on Biobanks and innovative medicine. Scientific coordination and management experience from several domestic and international projects. Co-organizers in various high level scientific meetings and events in national as well as global level. Selected in top ten among 100 most influential Finnish health care professionals 2014 by Medi-Uutiset weekly newspaper. More than 25 publications in the field of modern molecular biology.

    Jennifer Lorigan

    Lead Mediator, Dublin Brain Bank
    Jennifer Lorigan

    Jennifer Lorigan joined Dublin Brain Bank in December 2017 as Project Coordinator, a role which entails liaising with patients and researchers, preserving and storing samples, and conducting research. Previously, she has worked as a researcher in developmental biology, neuroscience, and tissue engineering laboratories. She has also worked in science communication and outreach for organisations including Science Gallery Dublin, Edinburgh International Science Festival, and Newstalk FM’s Futureproof. She holds an undergraduate degree in zoology and a Master’s in tissue engineering.

    Joe Pickrell

    CEO, Gencove
    Joe Pickrell

    Johanna Beekman

    Head Biosample Management, Bayer
    Johanna Beekman

    Johanna Beekman is Head Biosample Management within Research & Development of Bayer.
    Hanna received her PhD from the University of Groningen, Netherlands and worked as a researcher at Baylor College of Medicine, Houston before she joined Schering in Berlin, Germany in 1995. Here she worked in several research departments before joining the Biomarker department of Bayer in 2003. Hanna headed the Biomarker Laboratories for several years before founding the Biosample Management department in 2010.
    Biosample Management takes care of all operational aspects of biomarker, pharmacogenetic, immunogenicity and pharmacokinetic samples within Bayer’s clinical trials. The department is also responsible for the management of the Bayer Research Biobank and the Clinical Sample Repository
     

    Karine Sargsyan

    Leader of Biobank Graz, Medical University of Graz
    Karine Sargsyan

    v.h. Prof. Karine Sargsyan, pediatrician and psychologist, is a native Armenian. She joined the Medical University Graz, Austria (MUG) in 2005 within the scope of an international cooperation project after several years in Children’s Republican Hospital in Yerevan, Armenia were she led the Metabolism, Nutrition and Medical Dietetics department. She worked on and conducted several projects in health sector with the Ministry of Health and nongovernmental organizations. Since coming to Medical University Graz she worked for the Paediatric Department for a year and has written successful grant proposals collaboratively to fund research in hospital and central laboratory.
    She is since 2007 the Managing Director of Biobank Graz, and responsible not only for the general management of Biobank Graz but also for numerous scientific -research and training co-operative as well as developing projects. She was also the Scientific Director of multiregional Competence Project “Biomarkers for Personalized Medicine in Common Metabolic Disorders”, which consolidates more than 15 industrial and 5 academic partners under its roof. Currently (since 2012) she is holding also the position of IT manager in Biobank Graz and is/was responsible for acquisition and completion of many effective software programs. Together with her team, since 2007 she developed the Biobank Graz as an interdisciplinary institution. She has served in many managerial positions and worked internationally with different legal and funding authorities, government, sponsors and international organizations like WHO or BBMRI. Her professional performance has been recognized with more than 15 academic awards. Her expert career outside of academia includes consulting activities for pharma and biotech industry. An important aspect of her life is family -- her husband and daughter.
    Fundraising: over 30 Mio, Fund administration over 150 Mio
     

    Kristian Spreckley

    Business Development Director, UK Biocentre
    Kristian Spreckley

    Kristian Spreckley is the Business Development Director at UK Biocentre. Kristian’s main role is to engage with researcher’s around the country to understand their research needs and to build the National Biosample Centre’s service offering to enable world class scientific research. He has a background in genetics, specifically in the genetics of osteo and rheumatoid arthritis and started his career working on breast and prostate cancer. From their he moved into the commercial sector selling molecular biology instrumentation and then large-scale automation to the international biobanking industry before joining UK Biobank/ UK Biocentre.

    Marybeth Joshi

    Assistant Director, Duke University School of Medicine
    Marybeth Joshi

    Marybeth Joshi has spent more than 20 years directing complex, multi-faceted, multi-institutional, and multi-disciplinary clinical, translational, and basic science, as well as clinical outcomes research projects in oncology.

    For more than two decades, Marybeth has been instrumental in the development, implementation, and management of biospecimen and clinical data repositories and associated experimental data with the ability to transform working hypotheses into fully executable projects with defined benchmarks, goals, and measurable objectives.

    In 2010, she was asked to partner with Director of the Duke BioBank (now BioDuke) to move forward the institution’s goal of developing and implementing Duke University’s first enterprise-wide biorepository. This, lead to ensuring high-quality biospecimens, global institutional compliance with CAP and FDA regulations around biobanking and associated research, and maximization of biospecimen utility.

    In addition, she was asked to lead the enterprise-wide standardized biobanking terminology project to unify clinical research biobanking informatics.
    Currently, Marybeth serves as the School of Medicine’s Standard Terminology Manager for the enterprise-wide biobanking effort.
     

    Peadar Mac Gabhann

    Managing Director, Biostor Ireland
    Peadar Mac Gabhann

    Peadar Mac Gabhann graduated from the National University of Ireland, University College Dublin with a M.Sc. in Industrial Microbiology. He carried out post graduate research at the Netherlands Cancer Institute (NKI) Amsterdam, Biogen at ETH Zurich and the Faculty of Medicine at Kyoto University Japan. He joined Schering Plough Corporation (Merck) and was a key member of staff in the start-up of the first world-wide Biopharma facility in Cork for the production of Interferon in 1983. As Director and board member of Schering Plough Japan, he led the company’s research and Asian business development operations. Peadar has more than 30 years’ experience at the forefront of the international pharmaceutical industry. In the past 10 years he co-founded and directed two Life Science start-ups and participated in several international EU FP7 projects: He is a regular presenter at international events and has presented a position paper on “Biobanks - Key Resources for Advancement of Biotechnology & Human Health” to the expert group of the EU Parliament on the Future of Medicine. He is a national expert representing Ireland on the working group to establish a new ISO TC276 standard in Biobanking. He currently consults with Jacobs Engineering on the design and construction of major Biopharma facilities, he lectures part-time in Pharmaceutical Business at Griffith College Dublin as well as running a certified Tissue Establishment in Wexford, Biostór Ireland.
     

    Shona Kerr

    Project Manager, MRC Human Genetics Unit
    Shona Kerr

    Shona Kerr is a Project Manager of the QTL in Health and Disease programme at the MRC Human Genetics Unit, University of Edinburgh and Associate Director of the Edinburgh CRF Genetics Core. Her primary research interest is in the genetics of quantitative traits using human population and family-based biobanks (Generation Scotland and VIKING) and linked electronic health record data. She has Chaired the Generation Scotland Access Committee for three years, and still sits on that Committee to promote and implement data and sample sharing within a managed access framework

    Sofia Spyrou

    Project Manager, UK Stem Cell Bank
    Sofia Spyrou

    Sofia Spyrou has over five years of experience as a production manager. She joined the UK Stem Cell Bank at NIBSC in 2016 and currently manages the day to day banking operations. Her focus is to review, bank and distribute the MRC funded “EUTCD-Grade” human embryonic stem cell lines. This requires following the Human Tissue Authority’s directions on meeting the EU Tissue and Cells Directive. Sofia is responsible for overseeing the complete UK Stem Cell Bank banking process which includes due diligence, banking under GMP conditions, validated QC testing and distributing lines to both national and international customers.

    Sponsors and Exhibitors

    Supporters

    VENUE

    Holiday Inn Kensington Forum

    97 Cromwell Road , London, United Kingdom

    Holiday Inn Kensington Forum is perfectly situated in one of London’s most luxurious and beautiful areas within South Kensington. 

    The hotel is just 2 minutes walk from Gloucester Road tube station for convenient travel to Hyde Park, London Eye, Tower Bridge plus more of London’s top attractions. There are also easy and direct links to some major transport hubs including Victoria, Kings Cross St Pancras, Paddington and Heathrow. 

    This distinctive hotel in south London has so much to offer to make all guests really feel at home. The latest Holiday Inn relaunch is not just about the new look and feel for the hotel but to offer guests more benefits during their stay including a pillow menu for extra comfort during their sleep and a curved shower rail for more spacious feel. 

    In addition to our 906 rooms, all business guests can take advantage of our meeting and conference facilities including High Speed Internet Access and unlimited Starbucks coffee at The Academy. Our hotel’s professional event planners are on board to help take the hard work and stress away from planning your next event. 

    So whether you in London on business or pleasure, make the Holiday Inn London Kensington Forum your first choice of hotel and book your accommodation for our lowest internet rate guarantee. 

    HOTEL BOOKING FORM

    Past Attendee List 2017

    Download

    Sponsors and Exhibitors


    Modul-Bio

    Sponsors and Exhibitors
    http://www.modul-bio.com/en/

    Modul-Bio specializes in IT solutions for biological sample management, implementing barcode systems, Biokank Information Management Systems (BIMS) and collaborative tools for sharing biospecimen collections. We deploy software dedicated to biobanking for Biological Resource Centres, national cohort projects and biotechnology companies.


    Topa Thermal

    Sponsors and Exhibitors
    http://www.topathermal.com

    Topa Thermal is a global leading innovator and supplier of thermal systems, designed to support the safe distribution of medicines, vaccines and other life saving healthcare products for the pharmaceutical, biotech, medical industries and third party logistics. We provide a large selection of thermal packaging components and the most comprehensive engineering and testing services available in the industry. Our temperature assurance solutions keep your most valuable and sensitive products within a safe temperature range during transit. In our design and ISTA™ testing laboratory, we engineer packaging solutions that works for you, meeting your challenges in terms of specific time and temperature requirements.

    Media Partners


    Pharmalicensing

    Supporters
    http://www.pharmalicensing.com

    Pharmalicensing (www.pharmalicensing.com) is the premier biopharmaceutical Open Innovation resource designed for professionals involved with partnering, licensing and business development worldwide. Actively supporting all forms of partnering and in- and out-licensing activities, Pharmalicensing utilizes the unique Partnering Search service and its global network of industry experts to enable companies to identify and engage with appropriate partners around the world. Pharmalicensing, and its sister service Medical Device Licensing (www.medicaldevicelicensingcom) are actively utilized by over 200,000 industry professionals each month. Pharmalicensing is a division of IP Technology Exchange, Inc.


    Biosave

    Supporters
    http://www.Biosave.com

    Biosave.com brings together the best Life Science promotions, product releases, featured products, publications, videos and events from 100’s of leading Life Science suppliers. Updated 24 hours a day, Biosave is constantly uploading special promotions and exciting product news that you won’t find anywhere else. Our goal is to provide our users with the most exclusive product information to help reach that all important purchasing decision.


    Biopreservation & Biobanking Journal

    Supporters
    http://www.liebertpub.com/bio#utm_campaign=bio&utm_medium=conference&utm_source=smibio15

    Biopreservation and Biobanking is the first journal to provide a unifying forum for the peer-reviewed communication of recent advances in the emerging and evolving field of biospecimen procurement, processing, preservation, and banking. The Journal publishes a range of original articles focusing on current challenges and problems related to the processing of macromolecules, cells, and tissues. It also explores the ethical, legal, and societal considerations surrounding biobanking and biorepository operation.


    Mednous

    Supporters
    http://www.MedNous.com

    MedNous is a print publication and website about medical innovation in Europe. It carries exclusive interviews with companies that are at the forefront of medical technology, as well as contributor articles from prominent practitioners. Our mission is to identify significant advances in medicine and to explain how this innovation is being commercialised. In doing so, we talk to venture capitalists about what products and platforms they are supporting. We report on how regulators cope with the accelerating pace of innovation. And we regularly cover the latest developments in the discovery and development of new medical concepts in the area of antibodies, vaccines, small molecules, regenerative medicine and nanomedicines. MedNous combines the English word for medicine with the Greek word for intellect. And those with nous are readers of our publication. Visit our website: www.mednous.com


    Contract Biotechnology

    Supporters
    http://www.contract-biotechnology.com

    Contract-Biotechnology.com is a web-based platform for laboratory outsourcing solutions. We are an online R&D matching tool that connects Scientifics and organizations involved in discovery, development and delivery of new healthcare products with service and products providers worldwide. Life science information technology is undergoing a revolution. Part of that revolution involves new, unexplored business models, open innovation, open data and collaboration. If you have a project or idea that you would like to propose, develop or run, we can help. A New Collaboration Network Model for Discovery Research and Development • Effective Platform: the 95% • 5.000 registered users // > 15.000 Newsletter subscribers • Geographical background: 45,5% Europe / 37,5% North America / 16,5% Asia / 0,5% ROW • Professional background: Outsourcing Manager, Project Manager, CEO, Business Developer, CSO, Account Manager, Sales & Marketing People, Scientists, R&D. For further information, please visit our website www.contract-biotechnology.com


    GBI

    Supporters
    http://www.gbihealth.com/

    GBI is an information, applications, and services company focused on the healthcare industry. Leveraging data from across the healthcare value chain, GBI creates web and mobile applications that enable individuals and organizations to make better decisions and communicate more effectively.


    Technology Networks

    Supporters
    http://go.technologynetworks.com/subscribe-to-newsletters

    Founded in 2000, Technology Networks is established as the leading news provider for life science and drug discovery professionals. In addition, we provide unique content including webcasts, videos, application notes and posters from recent conferences. Our portfolio now includes around 30 focussed scientific communities, all of which are accessible free of charge within TechnologyNetworks.com


    Labsave

    Supporters
    http://www.labsave.com

    Labsave is the leading savings website for Laboratory Equipment and Lab Supplies. We work closely with the top suppliers in the world to bring you the best products at the most competitive prices. We are constantly striving to secure the biggest and most exclusive offers that you won’t find anywhere else! http://www.labsave.com/


    Drug Target Review

    Supporters
    http://www.drugtargetreview.com

    Drug Target Review’s quarterly magazine, website and annual events program provides high quality content with peer-written articles that are submitted exclusively by the world’s most respected scientists in their field. This attracts a committed base of readers, users and delegates made up of senior decision-makers from the life science and drug discovery industries at the top pharmaceutical companies, as well as academics and scientists from the top research institutes across the globe.


    Farmavita

    Supporters
    http://www.farmavita.net/

    Farmavita Net is professional community and network of pharmaceutical licensing and business development executives, innovators and researchers
    Farmavita.Net is the pharmaceutical licensing, technology transfer and regulatory affairs network. We are managing the marketplace of offers and demand for pharmaceutical Dossiers, know-how and technologies. Members of Farmavita.Net network usually find a number of attractive solutions for business development, alliances, joint ventures, co-development and co-marketing of pharmaceutical products. Farmavita.Net is not just a pure Internet portal. We manage a number of regional associates. We are connecting the dynamic network of few hundreds members / pharmaceutical companies interested in license-in and license-out opportunities.


    Pharmacircle

    Supporters
    http://www.pharmacircle.com

    PharmaCircle is an innovative knowledge management company serving the current and future global leaders in the Pharmaceutical and Biotechnology related industries. PharmaCircle is a one stop information and analysis source for pipeline, products, clinical trials, drug delivery technologies, deals and acquisitions, company financials, venture capital investments, product sales, pharmaceutical services, news, patents and more….


    Labiotech.eu

    Supporters
    https://goo.gl/DRE2Gp

    Labiotech.eu is the leading digital media covering the European Biotech industry. Over 100,000 monthly visitors use it to keep an eye on the business and innovations in biotechnology. Hope you'll enjoy reading our stories!


    BioChem Adda

    Supporters
    https://www.biochemadda.com/

    BioChem Adda is a Not-just-for-Profit organization which aims to bring out the most reliable and transparent information about everything related to jobs, careers, education, news, articles, and events from the field of BioSciences and Chemistry!


    Swiss Biotech Association

    Supporters
    http://www.swissbiotech.org/

    The Swiss Biotech Association (SBA) is the national industry association for biotechnology, including pharmaceuticals, diagnostics, agriculture, food, cosmetics, environmental biotechnology, and specialty chemicals. Members are companies active in modern biotechnology, such as R&D, Production, Marketing and Sales, Finance, Services and Consulting. SBA provides a networking platform for Life Science clusters, academic and federal institutions the like. Founded in March 1998, the Association grows steadily.


    Select Science

    Supporters
    http://www.selectscience.net/

    SelectScience is an independent, online information resource for the worldwide scientific community, and the home of trusted information for laboratory scientists. Discover impartial, expert opinion and trusted reviews about latest laboratory equipment and techniques; plus videos, application notes and science news from around the world. Become a member for free today.


    SciDoc Publishers

    Supporters
    http://www.scidoc.org

    SciDoc Publishers is a major source provider of e-journals in the field of Science, Technology and Medicine (STM). The nature of journals - Open Access and Peer-reviewed. We are aimed with a sole motive in making a mark in the field of Open Access, by propagating the knowledge to the scientific community. Our prime concern involves, the knowledge to reach millions of readers and give them access to scientific publications - online.


    Absave

    Supporters
    http://www.absave.com

    Absave.com is the leading savings website for Antibodies and Immunological Products. Search our extensive database of Antibodies, Kits, Proteins & Peptides, Reagents, etc. to find the best savings!


    Gate2Biotech

    Supporters
    http://www.gate2biotech.com

    Gate2Biotech is a portal that unites biotechnological community in Central Europe. It covers all the news in the field of biotechnology. Thanks to the the portal the companies engaged in the field can easily search for research institutions and other partners to solve technical problems they are facing and here they can also present their services offer to potential partners from the Czech Republic and abroad. Gate2Biotech portal serves as a bridge connecting scientific and commercial sector. It incorporates offices and support organizations dedicated to promoting transfer of innovative technologies into a unified communication platform of Czech and international biotechnologies. As a mediator of information it draws attention to biotechnologies and support of their application and transfer into practice. It also functions as a tool for encouraging non-professionals (especially scientists and students) towards innovative business or applied research.

    SAVE TO


    Outlook Calendar  OUTLOOK CALENDAR
    Google Calendar  GOOGLE CALENDAR
    ICal Calendar  ICAL CALENDAR
    Yahoo! Calendar  YAHOO! CALENDAR

    Holiday Inn Kensington Forum

    97 Cromwell Road
    London SW7 4DN
    United Kingdom

    Holiday Inn Kensington Forum

    Holiday Inn Kensington Forum is perfectly situated in one of London’s most luxurious and beautiful areas within South Kensington. 

    The hotel is just 2 minutes walk from Gloucester Road tube station for convenient travel to Hyde Park, London Eye, Tower Bridge plus more of London’s top attractions. There are also easy and direct links to some major transport hubs including Victoria, Kings Cross St Pancras, Paddington and Heathrow. 

    This distinctive hotel in south London has so much to offer to make all guests really feel at home. The latest Holiday Inn relaunch is not just about the new look and feel for the hotel but to offer guests more benefits during their stay including a pillow menu for extra comfort during their sleep and a curved shower rail for more spacious feel. 

    In addition to our 906 rooms, all business guests can take advantage of our meeting and conference facilities including High Speed Internet Access and unlimited Starbucks coffee at The Academy. Our hotel’s professional event planners are on board to help take the hard work and stress away from planning your next event. 

    So whether you in London on business or pleasure, make the Holiday Inn London Kensington Forum your first choice of hotel and book your accommodation for our lowest internet rate guarantee. 

    HOTEL BOOKING FORM

    Title

    SubTitle
    speaker image

    Content


    Title


    Description

    Download


    WHAT IS CPD?

    CPD stands for Continuing Professional Development’. It is essentially a philosophy, which maintains that in order to be effective, learning should be organised and structured. The most common definition is:

    ‘A commitment to structured skills and knowledge enhancement for Personal or Professional competence’

    CPD is a common requirement of individual membership with professional bodies and Institutes. Increasingly, employers also expect their staff to undertake regular CPD activities.

    Undertaken over a period of time, CPD ensures that educational qualifications do not become obsolete, and allows for best practice and professional standards to be upheld.

    CPD can be undertaken through a variety of learning activities including instructor led training courses, seminars and conferences, e:learning modules or structured reading.

    CPD AND PROFESSIONAL INSTITUTES

    There are approximately 470 institutes in the UK across all industry sectors, with a collective membership of circa 4 million professionals, and they all expect their members to undertake CPD.

    For some institutes undertaking CPD is mandatory e.g. accountancy and law, and linked to a licence to practice, for others it’s obligatory. By ensuring that their members undertake CPD, the professional bodies seek to ensure that professional standards, legislative awareness and ethical practices are maintained.

    CPD Schemes often run over the period of a year and the institutes generally provide online tools for their members to record and reflect on their CPD activities.

    TYPICAL CPD SCHEMES AND RECORDING OF CPD (CPD points and hours)

    Professional bodies and Institutes CPD schemes are either structured as ‘Input’ or ‘Output’ based.

    ‘Input’ based schemes list a precise number of CPD hours that individuals must achieve within a given time period. These schemes can also use different ‘currencies’ such as points, merits, units or credits, where an individual must accumulate the number required. These currencies are usually based on time i.e. 1 CPD point = 1 hour of learning.

    ‘Output’ based schemes are learner centred. They require individuals to set learning goals that align to professional competencies, or personal development objectives. These schemes also list different ways to achieve the learning goals e.g. training courses, seminars or e:learning, which enables an individual to complete their CPD through their preferred mode of learning.

    The majority of Input and Output based schemes actively encourage individuals to seek appropriate CPD activities independently.

    As a formal provider of CPD certified activities, SMI Group can provide an indication of the learning benefit gained and the typical completion. However, it is ultimately the responsibility of the delegate to evaluate their learning, and record it correctly in line with their professional body’s or employers requirements.

    GLOBAL CPD

    Increasingly, international and emerging markets are ‘professionalising’ their workforces and looking to the UK to benchmark educational standards. The undertaking of CPD is now increasingly expected of any individual employed within today’s global marketplace.

    CPD Certificates

    We can provide a certificate for all our accredited events. To request a CPD certificate for a conference , workshop, master classes you have attended please email events@smi-online.co.uk

    Event Title

    Headline

    Text
    Read More

    I would like to speak at an event

    I would like to attend an event

    I would like to sponsor/exhibit at an event

    SIGN UP OR LOGIN

    Sign up
    Forgotten Password?

    Contact SMi GROUP LTD

    UK Office
    Opening Hours: 9.00 - 17.30 (local time)
    SMi Group Ltd, 1 Westminster Bridge Road, London, SE1 7XW, United Kingdom
    Tel: +44 (0) 20 7827 6000 Fax: +44 (0) 20 7827 6001
    Website: http://www.smi-online.co.uk Email: events@smi-online.co.uk
    Registered in England No: 3779287 VAT No: GB 976 2951 71




    Forgotten Password

    Please enter the email address you registered with. We will email you a new password.